These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34102154)

  • 1. Long-term Outcomes of Boston Type I Keratoprosthesis, and Efficacy of Amphotericin B and Povidone-Iodine in Infection Prophylaxis.
    Prabhasawat P; Chotikavanich S; Ngowyutagon P; Pinitpuwadol W
    Am J Ophthalmol; 2021 Dec; 232():40-48. PubMed ID: 34102154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glaucoma associated with Boston type I keratoprosthesis.
    Kamyar R; Weizer JS; de Paula FH; Stein JD; Moroi SE; John D; Musch DC; Mian SI
    Cornea; 2012 Feb; 31(2):134-9. PubMed ID: 22134402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual Outcomes and Complications of Type I Boston Keratoprosthesis in Children: A Retrospective Multicenter Study and Literature Review.
    Fung SSM; Jabbour S; Harissi-Dagher M; Tan RRG; Hamel P; Baig K; Ali A
    Ophthalmology; 2018 Feb; 125(2):153-160. PubMed ID: 28807636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boston type 1 keratoprosthesis for failed keratoplasty.
    Hager JL; Phillips DL; Goins KM; Kitzmann AS; Greiner MA; Cohen AW; Welder JD; Wagoner MD
    Int Ophthalmol; 2016 Feb; 36(1):73-78. PubMed ID: 25975459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Keratoprostheses in silicone oil-filled eyes: long-term outcomes.
    Iyer G; Srinivasan B; Agarwal S; Pattanaik R; Rishi E; Rishi P; Shanmugasundaram S; Natarajan V
    Br J Ophthalmol; 2019 Jun; 103(6):781-788. PubMed ID: 30021817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to achieve best postoperative visual acuity following Boston keratoprosthesis surgery.
    El-Khoury J; Mustafa M; Daoud R; Harissi-Dagher M
    Br J Ophthalmol; 2022 Jul; 106(7):929-934. PubMed ID: 33658233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infectious keratitis after Boston type 1 keratoprosthesis implantation.
    Chan CC; Holland EJ
    Cornea; 2012 Oct; 31(10):1128-34. PubMed ID: 22960647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
    Greiner MA; Li JY; Mannis MJ
    Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of the MICOF keratoprosthesis surgery.
    Wang L; He X; Wang Q; Wu T; Liu A; Huang Y
    Ocul Surf; 2021 Jul; 21():178-185. PubMed ID: 34118425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
    Fadlallah A; Atallah M; Cherfan G; Awwad ST; Syed ZA; Melki SA
    Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual outcomes of Boston keratoprosthesis implantation as the primary penetrating corneal procedure.
    Kang JJ; de la Cruz J; Cortina MS
    Cornea; 2012 Dec; 31(12):1436-40. PubMed ID: 22367042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boston Type 1 Keratoprosthesis: Visual Outcomes, Device Retention, and Complications.
    Goins KM; Kitzmann AS; Greiner MA; Kwon YH; Alward WL; Ledolter J; Wagoner MD
    Cornea; 2016 Sep; 35(9):1165-74. PubMed ID: 27191675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boston type I keratoprosthesis versus penetrating keratoplasty following a single failed corneal graft.
    El-Khoury J; Khair D; Daoud R; Thompson P; Racine L; Harissi-Dagher M
    Eye (Lond); 2023 Feb; 37(3):486-491. PubMed ID: 35169272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Visual Outcomes, Complications, and Retention of the Boston Type I Keratoprosthesis.
    Aravena C; Yu F; Aldave AJ
    Cornea; 2018 Jan; 37(1):3-10. PubMed ID: 28990994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term Visual Outcomes and Complications of Boston Keratoprosthesis Type II Implantation.
    Lee R; Khoueir Z; Tsikata E; Chodosh J; Dohlman CH; Chen TC
    Ophthalmology; 2017 Jan; 124(1):27-35. PubMed ID: 27538795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mid-term prognosis of type I Boston keratoprosthesis reimplantation.
    Bouhout S; Robert MC; Harissi-Dagher M
    Br J Ophthalmol; 2022 Jan; 106(1):37-41. PubMed ID: 33055084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Boston Keratoprosthesis type 1 as primary penetrating corneal procedure.
    Fadous R; Levallois-Gignac S; Vaillancourt L; Robert MC; Harissi-Dagher M
    Br J Ophthalmol; 2015 Dec; 99(12):1664-8. PubMed ID: 26034079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermediate-Term and Long-Term Outcomes With the Boston Type 1 Keratoprosthesis in Aniridia.
    Shah KJ; Cheung AY; Holland EJ
    Cornea; 2018 Jan; 37(1):11-14. PubMed ID: 28990998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectious endophthalmitis after Boston type 1 keratoprosthesis implantation.
    Chan CC; Holland EJ
    Cornea; 2012 Apr; 31(4):346-9. PubMed ID: 22314825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of Boston keratoprosthesis type I: the Chinese People's Liberation Army General Hospital experience.
    Wang LQ; Wu TY; Chen XN; Xu ZQ; Yang M; Xiang R; Ma X; Zhang S; Huang YF
    Br J Ophthalmol; 2022 Jun; 106(6):781-785. PubMed ID: 33674425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.